Danaher Prices Senior Notes Offering

The company expects net proceeds of $1.79 billion from the offering, which will be used to partially fund its acquisition of Beckman Coulter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.